Boditech Med Inc. (KOSDAQ: 206640)

Boditech Med Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	139,134	134,219	118,077	157,708	144,131	72,799
Other Revenue	-0	-	-	-	-	-
Revenue	139,134	134,219	118,077	157,708	144,131	72,799
Revenue Growth (YoY)	14.95%	13.67%	-25.13%	9.42%	97.99%	9.96%
Cost of Revenue	54,794	53,724	47,443	59,516	46,697	31,977
Gross Profit	84,340	80,495	70,634	98,192	97,434	40,821
Selling, General & Admin	32,989	30,836	26,370	24,177	16,909	15,071
Research & Development	14,415	13,410	14,676	14,258	11,585	8,543
Other Operating Expenses	1,011	972.66	837.56	800.56	484.26	392.19
Operating Expenses	53,893	52,238	45,962	46,256	31,418	25,806
Operating Income	30,447	28,257	24,671	51,936	66,016	15,015
Interest Expense	-324.57	-350.39	-203.92	-196.5	-466.69	-1,731
Interest & Investment Income	974.73	663.8	332.21	344.11	97.28	112.78
Earnings From Equity Investments	432.86	312.38	-	-	-147.21	-
Currency Exchange Gain (Loss)	3,061	1,660	1,887	3,486	-2,833	546.7
Other Non Operating Income (Expenses)	714.9	711.81	568.61	1,106	-541.45	-445.88
EBT Excluding Unusual Items	35,307	31,255	27,255	56,676	62,125	13,498
Gain (Loss) on Sale of Investments	274.1	354.43	-330.2	-470.48	182.37	-219.17
Gain (Loss) on Sale of Assets	114.4	-48.18	43.62	-86.54	147.31	-4.43
Asset Writedown	-	-	-35.86	-79.44	-2,327	-211.54
Other Unusual Items	-	6.01	32.8	-	46.61	16.88
Pretax Income	35,695	31,567	26,965	56,039	60,174	13,079
Income Tax Expense	4,839	4,899	1,684	8,644	11,862	1,182
Earnings From Continuing Operations	30,856	26,668	25,281	47,395	48,312	11,897
Minority Interest in Earnings	-418.49	-721.75	-1,130	-3,028	-2,823	-247.03
Net Income	30,438	25,947	24,152	44,367	45,489	11,650
Net Income to Common	30,438	25,947	24,152	44,367	45,489	11,650
Net Income Growth	34.63%	7.43%	-45.56%	-2.47%	290.47%	-
Shares Outstanding (Basic)	22	22	22	23	23	23
Shares Outstanding (Diluted)	22	22	22	23	23	23
Shares Change (YoY)	-0.76%	-1.77%	-2.41%	-0.47%	0.14%	-0.24%
EPS (Basic)	1386.24	1181.10	1079.94	1937.17	1978.15	506.66
EPS (Diluted)	1386.14	1181.00	1079.94	1936.26	1975.90	506.66
EPS Growth	35.65%	9.36%	-44.23%	-2.01%	289.98%	-
Free Cash Flow	23,875	29,695	7,808	31,697	40,565	12,535
Free Cash Flow Per Share	1087.36	1351.72	349.13	1383.14	1761.80	545.14
Dividend Per Share	200.000	200.000	150.000	200.000	200.000	50.000
Dividend Growth	33.33%	33.33%	-25.00%	0%	300.00%	0%
Gross Margin	60.62%	59.97%	59.82%	62.26%	67.60%	56.07%
Operating Margin	21.88%	21.05%	20.89%	32.93%	45.80%	20.63%
Profit Margin	21.88%	19.33%	20.45%	28.13%	31.56%	16.00%
Free Cash Flow Margin	17.16%	22.12%	6.61%	20.10%	28.14%	17.22%
EBITDA	38,656	36,489	32,144	57,977	71,406	20,098
EBITDA Margin	27.78%	27.19%	27.22%	36.76%	49.54%	27.61%
D&A For EBITDA	8,208	8,232	7,473	6,041	5,389	5,083
EBIT	30,447	28,257	24,671	51,936	66,016	15,015
EBIT Margin	21.88%	21.05%	20.89%	32.93%	45.80%	20.63%
Effective Tax Rate	13.56%	15.52%	6.24%	15.43%	19.71%	9.04%
Advertising Expenses	-	1,149	962.7	686.79	318.55	684.25

Source: S&P Capital IQ. Standard template. Financial Sources.